2 results
Alert
AI, data and the 2026 life sciences investment playbook
Healthy returns: US life sciences M&A on track for a banner year
Insight
Healthy returns: US life sciences M&A on track for a banner year
M&A Explorer | AI-driven innovation, pent-up demand and ample financial firepower are fueling dealmaking in the sector